Urbanowicz Tomasz, Kociemba Anna, Pyda Małgorzata, Katyńska Izabela, Straburzyńska-Migaj Ewa, Baszyńska-Wachowiak Hanna, Misterski Marcin, Grajek Stefan, Jemielity Marek
Department of Cardiac Surgery and Transplantology, Chair of Cardio-Thoracic Surgery, Poznań University of Medical Sciences, Poznań, Poland.
Department of Cardiology, Poznań University of Medical Sciences, Poznań, Poland.
Ann Transplant. 2014 Sep 8;19:447-51. doi: 10.12659/AOT.890906.
Diagnosis of rejection is a major objective in the management of heart transplant recipients. It has been reported that one-third of protocol biopsies in asymptomatic, biochemically stable organ transplant recipients in the first 6 months show unsuspected subclinical graft rejection.
We present the case of a 43-year-old man suffering from dilated cardiomyopathy who underwent orthotropic heart transplantation. The patient was admitted for a protocol endomyocardial biopsy and magnetic resonance imaging (MRI) on the 4th postoperative month as a protocol procedure. The examination revealed clinical status NYHA I with no signs of fatigue, diminution of exercise tolerance, or shortness of breath. His body temperature was not raised. He was referred for endomyocardial biopsy and cardiovascular magnetic resonance (CMR) imaging. CMR imaging showed good left and right ventricle function and contractility. T2 imaging revealed increased signal in the area of the right ventricular free wall, seen both in 4-chamber and short axis views. The patient underwent an endomyocardial biopsy, which demonstrated diffuse infiltrate with multifocal miocyte damage and cellular edema recognized as acute rejection (3a ISHLT grade). Consequently, he was treated with parenteral methylprednisolone administration. The CMR study performed after 1 week of therapy showed that the signal intensity of the edematous areas was significantly decreased. Repetitive endomyocardial biopsy revealed no signs of rejection.
CMR can be helpful in graft monitoring following heart transplantation. It gives a whole-heart perspective that can be competitive with and/or complementary to endomyocardial biopsy. As a noninvasive study it can be applied more often and facilitates diagnosis of asymptomatic rejection episodes.
排斥反应的诊断是心脏移植受者管理中的主要目标。据报道,在无症状、生化指标稳定的器官移植受者中,三分之一的术后6个月内的常规活检显示存在未被怀疑的亚临床移植物排斥反应。
我们报告一例43岁扩张型心肌病男性患者,接受了原位心脏移植。术后第4个月,患者因常规检查入院接受心内膜心肌活检和磁共振成像(MRI)。检查显示其纽约心脏协会(NYHA)心功能分级为I级,无疲劳、运动耐量下降或呼吸急促的迹象。体温未升高。他被转诊进行心内膜心肌活检和心血管磁共振(CMR)成像。CMR成像显示左、右心室功能及收缩性良好。T2成像显示右心室游离壁区域信号增强,在四腔心和短轴视图中均可见。患者接受了心内膜心肌活检,结果显示弥漫性浸润伴多灶性心肌细胞损伤和细胞水肿,确诊为急性排斥反应(国际心脏和肺移植协会[ISHLT]3a级)。因此,对其进行了静脉注射甲泼尼龙治疗。治疗1周后进行的CMR研究显示,水肿区域的信号强度显著降低。重复的心内膜心肌活检未发现排斥反应迹象。
CMR有助于心脏移植后的移植物监测。它提供了全心视角,可与心内膜心肌活检相媲美和/或互补。作为一种非侵入性检查,它可以更频繁地应用,有助于诊断无症状排斥反应发作。